Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus

Janet K. Yamamoto, Tsutomu Hohdatsu, Robert A. Olmsted, R Pu, Harry Louie, Howard Zochlinski, Verónica Acevedo, Howard M. Johnson, G A Soulds, M B Gardner

Journal of Virology · 1993 · 105 citations · 13 references

DOIFull text

Open access

Concepts

Abstract

More than 90% of cats immunized with inactivated whole infected-cell or cell-free feline immunodeficiency virus (FIV) vaccines were protected against intraperitoneal infection with 10 50% animal infectious doses of either homologous FIV Petaluma (28 of 30 cats) or heterologous FIV Dixon strain (27 of 28 cats). All 15 control cats were readily infected with either strain of FIV. Protection appears to correlate with antiviral envelope antibody levels by a mechanism yet to be determined.

References

13